Organization · Venture Capital
Siryo S.p.A.
Siryo S.p.A. is a venture capital firm based in Bari, Italy, focusing on disruptive technologies in materials science to enhance human and environmental health. It supports innovative startups in sectors such as Food/Health, Biomaterials, and Energy & Environment.
Overview
What Siryo S.p.A. does
What Siryo S.p.A. is
Siryo S.p.A. is a venture capital firm based in Bari, Italy, focusing on disruptive technologies in materials science to enhance human and environmental health. It supports innovative startups in sectors such as Food/Health, Biomaterials, and Energy & Environment.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- March 27, 2026
Official channels
Find Siryo S.p.A. elsewhere
Open the official website or a supported primary organization account.
Capability profile
Siryo S.p.A. as a funder
Investment thesis
Siryo S.p.A. focuses on disruptive technologies in materials science aimed at enhancing human and environmental health, known as the One-Health approach.
Focus narrative
Siryo invests in innovative technologies and start-ups across sectors such as Food/Health, Biomaterials, and Energy & Environment. The company employs a modern Venture Studio approach, which includes structured selection processes and active management support, targeting various investment stages including Seed Capital, Start-up Capital, Spin-offs, and Expansion Capital.
Value beyond capital
Siryo adds value to its portfolio companies by providing not only financial support but also operational tools and management expertise, helping them navigate the complexities of bringing innovative technologies to market.
Terms and economics
- Typical check
- $500,000–$10,000,000
Focus and fit
- Stages
- Seed · Seed+ · Series A · Series B · Growth Equity
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 8
Portfolio context
Siryo's portfolio includes several notable projects such as Siryo T.E.C. S.r.l., Oxoco S.r.l., Votis Postbiotica S.r.l., Oloker Therapeutics S.r.l., Celery S.r.l., EggPlant S.r.l., and Typeone Biomaterials S.r.l.
Common questions
What to know about Siryo S.p.A.
Upseed classifies Siryo S.p.A. under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.